State Street Corp Intercept Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$9.99 - $18.71 $9.81 Million - $18.4 Million	-982,414 Reduced 23.5%	3,197,810 $59.3 Million
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $10.3 Million - $21.7 Million	1,125,714 Added 36.85%	4,180,224 $46.2 Million
Q1 2023 May 15, 2023	SELL	$12.53 - $21.71 $1.52 Million - $2.64 Million	-121,415 Reduced 3.82%	3,054,510 $41 Million
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $1.44 Million - $2 Million	124,341 Added 4.07%	3,175,925 $39.3 Million
Q3 2022 Nov 15, 2022	SELL	$12.21 - $19.7 $5.19 Million - $8.37 Million	-425,048 Reduced 12.23%	3,051,584 $42.6 Million
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $2.86 Million - $4.99 Million	254,800 Added 7.91%	3,476,632 $48 Million
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $433,642 - $577,000	-32,434 Reduced 1.0%	3,221,832 $52.4 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $1.55 Million - $2.13 Million	108,825 Added 3.46%	3,254,266 $53 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $6.35 Million - $10 Million	488,857 Added 18.4%	3,145,441 $46.7 Million
Q2 2021 Aug 16, 2021	SELL	$15.46 - $24.5 $2.76 Million - $4.38 Million	-178,758 Reduced 6.3%	2,656,584 $53.1 Million
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $5.5 Million - $10.7 Million	284,592 Added 11.16%	2,835,342 $65.4 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $21.1 Million - $36.6 Million	860,697 Added 50.93%	2,550,750 $63 Million
Q3 2020 Nov 10, 2020	BUY	$39.09 - $53.44 $17 Million - $23.3 Million	435,702 Added 34.74%	1,690,053 $70.1 Million
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $4.6 Million - $9.07 Million	98,552 Added 8.53%	1,254,351 $60.1 Million
Q1 2020 May 11, 2020	BUY	$48.35 - $118.68 $55.9 Million - $137 Million	1,155,799 New	1,155,799 $72.8 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account